BackLakeShore Biopharma Co Ltd. - Warrants (15/03/2028) Overview
LakeShore Biopharma Co Ltd. - Warrants (15/03/2028)

LakeShore Biopharma Co Ltd. - Warrants (15/03/2028) Return on Equity

Valuation check: LSBPW's ROE is -42.28%, below the sector sector average of 11.64%.

Get informed when a big investor buys or sells

+ Follow

ROE

-42.28%

Return on Equity

-42.28%

Return on Equity measures how efficiently a company uses shareholders' equity to generate profits. A higher ROE indicates better profitability relative to equity.

ROE (Comparison Companies)

Loading

ROE History

Loading

ROE Comparison

Loading

LakeShore Biopharma Co Ltd. - Warrants (15/03/2028) (LSBPW) FAQ

LakeShore Biopharma Co Ltd. - Warrants (15/03/2028) (LSBPW) currently reports a ROE of -42.28%. That is below the sector sector average of 11.64%. Use the charts on this page to explore LakeShore Biopharma Co Ltd. - Warrants (15/03/2028)'s ROE history and peer comparisons.

LakeShore Biopharma Co Ltd. - Warrants (15/03/2028)'s ROE of -42.28% is lower than the its sector sector average of 11.64%. That is roughly 463.4% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

There is no universal 'good' ROE, but LakeShore Biopharma Co Ltd. - Warrants (15/03/2028)'s current -42.28% should be judged against industry norms (sector average: 11.64%) and against LSBPW's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.

Start with the current ROE of -42.28%, then check the historical chart for trend and the peer comparison chart for relative positioning. The sector average is 11.64%. From there, open related valuation or income-statement pages for LakeShore Biopharma Co Ltd. - Warrants (15/03/2028), and consider following LSBPW for alerts when major investors trade the stock.